According to the latest report by IMARC Group, titled, "Microbiome Sequencing Services Market Report: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026, "the global microbiome sequencing services market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 21% during 2021-2026.

Microbiome sequencing services aid in determining the function of the microbiome in human health and disease pathogenesis by utilizing next-generation sequencing (NGS) instruments. They primarily include functional profiling, alpha-diversity, beta-diversity, virulence factor identification, LEfSe biomarker discovery, clustering heatmap, etc. These services offer comprehensive bioinformatics and statistical analyses in an interactive and user-friendly report, along with faster and more accurate classification compared to conventional identification methods, such as cloning and culturing.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/microbiome-sequencing-services-market/requestsample

Market Trends

The expanding pharmaceutical sector across the globe is among the key factors driving the microbiome sequencing services market. Moreover, the rising prevalence of colorectal cancer (CRC) owing to various factors, including the increasing occurrences of inflammatory intestinal conditions and consumption diets with low fiber and high fat content, is further stimulating the market growth. Apart from this, the escalating demand for early disease detection and diagnosis is further augmenting the global market. Furthermore, the growing applications of microbiome sequencing services in academia and research institutes for protein and small molecule analysis are catalyzing the product demand. Additionally, microbiome content is widely gaining traction as a biomarker for different diseases owing to faster and cost-effective sequencing platforms and data analysis pipelines, which is propelling the market. Besides this, the increasing focus on customizing gut microbial consortia to develop advanced individualized medicine, coupled with advancements in genomic research, are expected to drive the microbiome sequencing services market over the forecasted period.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

BaseClear B.V.
Clinical-Microbiomics A/S
Diversigen Inc (OraSure Technologies Inc.)
Mérieux NutriSciences
Metabiomics Corporation (BioSpherex LLC)
Microbiome Insights Inc.
Microbiome Therapeutics LLC
Molecular Research LP
Molzym GmbH & Co. KG
Resphera Biosciences LLC
Shanghai Realbio Technology (RBT) Co. Ltd.
Zymo Research Corporation.

The report has segmented the market based on technology, research type, laboratory type, application and end user.

Breakup by Technology:

Sequencing by Synthesis (SBS)
Sequencing by Ligation (SBL)
Pyrosequencing
Sanger Sequencing
Others

Breakup by Research Type:

Outsourced Research
Internal Research

Breakup by Laboratory Type:

Dry Labs
Wet Labs

Breakup by Application:

Shotgun Sequencing
Targeted Gene Sequencing
RNA Sequencing
Whole Genome Sequencing
Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies
Research and Academic Institutes
Others

Breakup by Region:

North America
Asia-Pacific
Europe
Latin America
Middle East and Africa

Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/microbiome-sequencing-services-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us

30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal